Tenalisib
Tenalisib, also known as RP6530, is a potent and selective dual PI3Kδ/γ inhibitor that inhibits the growth of B-cell lymphoma cell lines while reducing the downstream biomarker pAKT.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0202 |
| Pricing | 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire |